WO1996001906A1 - Kinetisch kontrolliertes verfahren zur enzymatischen herstellung von peptiden - Google Patents
Kinetisch kontrolliertes verfahren zur enzymatischen herstellung von peptiden Download PDFInfo
- Publication number
- WO1996001906A1 WO1996001906A1 PCT/EP1995/002655 EP9502655W WO9601906A1 WO 1996001906 A1 WO1996001906 A1 WO 1996001906A1 EP 9502655 W EP9502655 W EP 9502655W WO 9601906 A1 WO9601906 A1 WO 9601906A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- biocatalyst
- choline
- compound
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to a method for producing peptides.
- the invention is directed to a kinetically controlled peptide synthesis using enzymes, in which fully protected amino acids or peptides of the formula I
- Y is a protecting group other than Y 'and A 2 is a
- the object of the invention is therefore to provide a further process for the preparation of peptides in high yield and selectivity, which enables the enzymatic conversion of as many different substrates as possible under the catalytic action of a large number of different biocatalysts.
- Choline esters are widespread biomolecules and are known per se. In addition, there have also been investigations into the use of choline ester compounds as substrates for the hydrolysis using ⁇ -chymotrypsin
- Useful compounds of the formula (I) which are fully protected in the context of the invention include all choline esters with X-protected amino acids or peptides or their salts. Possible u. a. Choline ester chloride, bromide, hydrogen tartra, hydrogen citra, ascorbate, hydrogen bromide; Choline ester hydrogen bromide is particularly preferred according to the invention.
- the compounds of the formula (I) can be obtained by processes familiar to the person skilled in the art. Exemplary syntheses are in H. Kunz and M. Buchholz, Chem. Ber. , 1979, 112, 2145.
- Known protecting groups X were used to protect the N-terminal end. These include the Z group (benzyloxycarbonyl), the Boc group (t-butyloxycarbonyl) and various other acyl groups (acetyl, phenacetyl, formyl).
- the compounds of formula (II) are known Y-protected amino acids or peptides.
- Exemplary Y-protecting groups are in a non-exhaustive list e.g. B. methyl, ethyl, benzyl, nitrobenzyl, tert-butyl, amide and others called.
- the ethyl or benzyl radical or the amide group are preferred for the invention.
- the compounds of the formula (II) can also be obtained by processes known from the literature. Helpful hints can be found in the Organikum, VEB-Verlag, 8th ed., 1968.
- biocatalysts which can advantageously be used in the process according to the invention include a large number of different esterases or else serine or thiol proteases.
- choline esterases and proteases such as. B. chymotrypsin, papain, trypsin, subtilopeptidase A, Nagarse and proteinase K according to the invention of great interest.
- biocatalysts are ⁇ -chymotrypsin and / or trypsin.
- the process according to the invention for peptide production can be carried out extremely advantageously in an aqueous medium.
- aqueous medium This is to be understood as either essentially pure water or water, which may have additions of less polar solvents, such as C1-C4 alcohols, in amounts of up to 50% by weight.
- the process of the invention is characterized in that an aqueous solution of the compound of the formula (I) (acyl donor) precooled to temperatures ⁇ 10 ° C., preferably about 0 ° C., to give the compound of the formula (II) (Acyl acceptor) and the biocatalyst-containing aqueous solution, which is preferably likewise pre-cooled to about 0 ° C., is added in such a way that an excess of the compound of the formula (II) is constantly guaranteed over the addition period.
- the procedure is preferably such that a solution of the acyl donor precooled to 0 ° C. is slowly added dropwise to a likewise ice-cooled solution (pH 7.8) which contains the acyl acceptor and the biocatalyst, so that an excess of nucleophile is ensured.
- the peptide bond is usually linked very quickly by the protease.
- U. the precipitated peptides can be isolated in analytically pure form with yields of 60-82%.
- the choline esters are usually synthesized separately from the enzymatic reaction and then used as the starting compound of the formula I in the process according to the invention. However, they can also be prepared together with the peptide synthesis from corresponding precursors.
- X and A 1 have the meaning given for formula I and OEt-Hal stands for the chlorine, bromine or iodoethyl ester group, but particularly preferably for the bromoethyl ester group, and trimethylamine is prepared, preferably the trimethylamine to an aqueous solution which Compound of formula IV containing the biocatalyst and the compound of formula II is added.
- Compound of formula I (acyl donor) corresponding halogen ethyl ester, particularly preferably bromoethyl ester, the compound of formula II (acyl acceptor) and Biocatalyst contains, preferably a cooled aqueous trimethylamine solution is added so that the amount of trimethylamine is just sufficient for the in-situ formation of the choline ester corresponding to the haloethyl ester, which then reacts enzymatically to the protected dipeptide, that is, by the "in-situ formation "of the choline ester, the separate synthesis of the choline ester before the enzymatic reaction is superfluous, but the good reactivity of the choline ester as a compound of the formula I (acyl donor) is exploited.
- choline esters are used as carboxyl components for kinetically controlled peptide synthesis.
- choline esters are well suited carboxy components for kinetically controlled peptide synthesis.
- the solubilizing effect of the leaving group enables reactions to be carried out in the aqueous reaction medium with the advantage of product precipitation with a corresponding choice of reactants.
- the enzymes used in the examples below are commercial enzyme preparations, the first time in which the reference source is given.
- trypsin commercial product from Serva
- subtilopeptidase A commercial product from Boehringer
- Z-Phe-OCh + Br " , 50 mM H-Leu-NH2 and 0.03 ⁇ M subtilopeptidase A give a peptide yield of 29% at -15 ° C in a frozen aqueous system after a reaction time of 30 h and complete ester consumption (at room temperature after 1 h and with complete ester consumption the peptide yield was 3.5%).
- the peptide yield after 30 h at an enzyme concentration of 0.06 ⁇ M in the reaction mixture and complete ester consumption was 31.1% of theory. Th., While at room temperature after 4 h the peptide yield was only 5.1%.
- Example 4 As in Example 4, 0.465 g (1 mmol) of Z-Phe-OCh + Br " and 0.675 g (2 mmol) of H-Gly-OBzl * p-Tos are reacted at pH 7.5 with 5 mg of ⁇ -chymotrypsin.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95930417A EP0769066A1 (de) | 1994-07-08 | 1995-07-07 | Kinetisch kontrolliertes verfahren zur enzymatischen herstellung von peptiden |
JP8504120A JPH10502258A (ja) | 1994-07-08 | 1995-07-07 | 速度制御された、酵素によるペプチドの製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4423724A DE4423724A1 (de) | 1994-07-08 | 1994-07-08 | Kinetisch kontrolliertes Verfahren zur enzymatischen Herstellung von Peptiden |
DEP4423724.3 | 1994-07-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996001906A1 true WO1996001906A1 (de) | 1996-01-25 |
Family
ID=6522413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1995/002655 WO1996001906A1 (de) | 1994-07-08 | 1995-07-07 | Kinetisch kontrolliertes verfahren zur enzymatischen herstellung von peptiden |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0769066A1 (de) |
JP (1) | JPH10502258A (de) |
DE (1) | DE4423724A1 (de) |
WO (1) | WO1996001906A1 (de) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278787A1 (de) * | 1987-02-13 | 1988-08-17 | Carlbiotech Ltd. A/S | Verfahren zur enzymatischen Herstellung von Dipeptiden |
DE4101895C1 (de) * | 1991-01-23 | 1991-12-05 | Forschungszentrum Juelich Gmbh, 5170 Juelich, De | |
WO1991019811A1 (de) * | 1990-06-13 | 1991-12-26 | Hoechst Aktiengesellschaft | Verfahren zur herstellung von peptiden |
-
1994
- 1994-07-08 DE DE4423724A patent/DE4423724A1/de not_active Withdrawn
-
1995
- 1995-07-07 WO PCT/EP1995/002655 patent/WO1996001906A1/de not_active Application Discontinuation
- 1995-07-07 JP JP8504120A patent/JPH10502258A/ja active Pending
- 1995-07-07 EP EP95930417A patent/EP0769066A1/de not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278787A1 (de) * | 1987-02-13 | 1988-08-17 | Carlbiotech Ltd. A/S | Verfahren zur enzymatischen Herstellung von Dipeptiden |
WO1991019811A1 (de) * | 1990-06-13 | 1991-12-26 | Hoechst Aktiengesellschaft | Verfahren zur herstellung von peptiden |
DE4101895C1 (de) * | 1991-01-23 | 1991-12-05 | Forschungszentrum Juelich Gmbh, 5170 Juelich, De |
Non-Patent Citations (2)
Title |
---|
KUNZ ET AL.: "Das System 2-Halogenethylester / Cholinester als zweistufen-Schutzgruppe für die Carboxylfunktion von Aminosäuren und Peptiden", CHEM. BER., vol. 112, no. 6, pages 2145 - 2157 * |
SCHELLENBERGER ET AL.: "Specific water-soluble substrates for chymotrypsin : attemps for compensating diminished P1-S1 interactions", COLL. CZECHOSLOVAK CHEM. COMMUN., vol. 53, no. 11b, pages 2884 - 2889 * |
Also Published As
Publication number | Publication date |
---|---|
DE4423724A1 (de) | 1996-01-11 |
JPH10502258A (ja) | 1998-03-03 |
EP0769066A1 (de) | 1997-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0496373B1 (de) | Verfahren zur enzymatischen Herstellung geschützter und ungeschützter Di- und Oligopeptide in wässrigen Lösungen | |
EP0020290A1 (de) | Verfahren zur spezifischen Abspaltung von Proteinsequenzen aus Proteinen | |
DE3424440C2 (de) | ||
EP0839153B1 (de) | Verfahren zur herstellung von peptiden und n-carbamoyl-geschützten peptiden | |
EP1054996B1 (de) | Verfahren zur enzymatischen auflösung von laktamen | |
EP0003786A1 (de) | Stereoselektive Spaltung von Phenylglycinderivaten und 4-Hydroxyphenylglycinderivaten mit Enzymharzen | |
EP0176068B1 (de) | Verfahren zur Herstellung der Stereoisomeren von 1-Amino-alkylphosphonsäuren oder 1-Amino-alkylphosphinsäuren | |
WO1996001906A1 (de) | Kinetisch kontrolliertes verfahren zur enzymatischen herstellung von peptiden | |
EP0474212B1 (de) | Enzymatisches Verfahren zur Umwandlung von Präproinsulinen zu Insulinen | |
EP1200601B1 (de) | Verfahren zur herstellung von l-aminosäuren aus ihren racemischen n-acetyl-d,l-derivaten durch enzymatische racemat-spaltung mittels isolierter, rekombinanter enzyme | |
US6174707B1 (en) | Process for producing L-allysine acetals | |
EP0377083B1 (de) | Verfahren zur Herstellung von L-alpha-Aminosäuren | |
DE4014564C1 (de) | ||
Stoineva et al. | Chemical-enzymatic incorporation of D-amino acids into peptides: synthesis of diastereomeric (D-Ala2, D-Leu5) enkephalinamides | |
Kuhl et al. | On the use of carboxamidomethyl esters in the protease-catalyzed peptide synthesis | |
EP0534992B1 (de) | Verfahren zur herstellung von peptiden | |
EP0518088A2 (de) | Verfahren zur Clostripain-katalysierten Verknüpfung von Arg-Pro und Arg-B (B=proteinogene und nicht-proteinogene Aminosäuren) enthaltenden Peptiden | |
EP0310012A2 (de) | Verfahren zur Herstellung von optisch reinem Homophenylalanin | |
EP0407909B1 (de) | Verfahren zur Herstellung von R-(+)-3-Oxocycloalkancarbonsäureniederalkylestern | |
DE19607100C2 (de) | Verfahren zur Herstellung von Peptiden und N-Carbamoyl-geschützten Peptiden | |
EP0529601B1 (de) | Verfahren zur Herstellung von optisch aktivem Vinylglycin in freier oder geschützter Form über eine enzymatische, enantioselektive Hydrolyse | |
DE3803124C2 (de) | ||
EP0623680B1 (de) | Verfahren zur Herstellung von Peptiden und Verwendung | |
DE602004005947T2 (de) | Verfahren zur Herstellung einer optisch aktiven Octahydro-1H-Indol-2-Carbonsäure | |
EP0514780A2 (de) | Verfahren zur Herstellung enantiomerenreiner offenkettiger N-Alkyl-L oder D-aminosäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995930417 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1995930417 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 776332 Date of ref document: 19970501 Kind code of ref document: A Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995930417 Country of ref document: EP |